ExonHit Extends Strategic Collaboration with Allergan

ExonHit S.A. today announced the extension of its existing drug discovery collaboration with Allergan Sales, LLC (NYSE: AGN). The collaboration was initiated in December 2002, and extended several times. It now is further extended until December 2013. The collaboration will continue to focus on the identification, development and commercialization of drugs for the treatment of neurodegenerative diseases, pain and ophthalmology.

Detailed financial terms were not disclosed.